« Back
Home /
Doxycycline Hyclate

Doxycycline Hyclate

Item no.	M4907-10mM
Manufacturer	AbMole
Amount	10mM*1mL
Category	Oncology Neuroscience Neural Lineage Markers By Cell Type Blastoma Carcinoma Cell Biology Cell Status Proliferation Inhibitors & Compound Libraries Small Molecules By Organ Bladder Cancer Heart & Blood Cancer
Type	Inhibitors
Specific against	other
ECLASS 10.1	32160490
ECLASS 11.0	32160490
UNSPSC	12000000
Available
Cas #	24390-14-5
Bioactivity information	Doxycycline hyclate is an effective treatment for acute E. canis infection in dogs. Doxycycline hyclate results in bioavailability of 70%, Cmin of 1 mg/L, Cmax of 2.3 mg/L and elimination half-life of 7 hours in calves with immature rumen function.Doxycycline hyclate results in 43% of prophylaxis in orally treated mice, in contrast, the sustained-release doxycycline hyclate completely protects mice from infection and resultant pathology.
Target	MMP
Synonyms	Doxycycline hydrochloride hemiethanolate hemihydrate, WC2031
MW	512, 94
Formula	C22H24N2O8.1/2C2H6O.HCl.1/2H2O
Solubility	DMSO 100 mg/mL; Water 100 mg/mL
Purity	>97%

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

M4907-10mM-safety-datasheet.pdf